191 related articles for article (PubMed ID: 30118657)
1. The HU177 Collagen Epitope Controls Melanoma Cell Migration and Experimental Metastasis by a CDK5/YAP-Dependent Mechanism.
Caron JM; Han X; Contois L; Vary CPH; Brooks PC
Am J Pathol; 2018 Oct; 188(10):2356-2368. PubMed ID: 30118657
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of Ovarian Tumor Growth by Targeting the HU177 Cryptic Collagen Epitope.
Caron JM; Ames JJ; Contois L; Liebes L; Friesel R; Muggia F; Vary CP; Oxburgh L; Brooks PC
Am J Pathol; 2016 Jun; 186(6):1649-61. PubMed ID: 27216148
[TBL] [Abstract][Full Text] [Related]
3. Disruption of endothelial cell interactions with the novel HU177 cryptic collagen epitope inhibits angiogenesis.
Cretu A; Roth JM; Caunt M; Akalu A; Policarpio D; Formenti S; Gagne P; Liebes L; Brooks PC
Clin Cancer Res; 2007 May; 13(10):3068-78. PubMed ID: 17505010
[TBL] [Abstract][Full Text] [Related]
4. Identification of an Endogenously Generated Cryptic Collagen Epitope (XL313) That May Selectively Regulate Angiogenesis by an Integrin Yes-associated Protein (YAP) Mechano-transduction Pathway.
Ames JJ; Contois L; Caron JM; Tweedie E; Yang X; Friesel R; Vary C; Brooks PC
J Biol Chem; 2016 Feb; 291(6):2731-50. PubMed ID: 26668310
[TBL] [Abstract][Full Text] [Related]
5. Shedding of distinct cryptic collagen epitope (HU177) in sera of melanoma patients.
Ng B; Zakrzewski J; Warycha M; Christos PJ; Bajorin DF; Shapiro RL; Berman RS; Pavlick AC; Polsky D; Mazumdar M; Montgomery A; Liebes L; Brooks PC; Osman I
Clin Cancer Res; 2008 Oct; 14(19):6253-8. PubMed ID: 18829505
[TBL] [Abstract][Full Text] [Related]
6. Nuclear Localization of Yes-Associated Protein Is Associated With Tumor Progression in Cutaneous Melanoma.
Ryu HJ; Kim C; Jang H; Kim SI; Shin SJ; Chung KY; Torres-Cabala C; Kim SK
Lab Invest; 2024 May; 104(5):102048. PubMed ID: 38490470
[TBL] [Abstract][Full Text] [Related]
7. Collagen abundance controls melanoma phenotypes through lineage-specific microenvironment sensing.
Miskolczi Z; Smith MP; Rowling EJ; Ferguson J; Barriuso J; Wellbrock C
Oncogene; 2018 Jun; 37(23):3166-3182. PubMed ID: 29545604
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of angiogenesis and tumor metastasis by targeting a matrix immobilized cryptic extracellular matrix epitope in laminin.
Akalu A; Roth JM; Caunt M; Policarpio D; Liebes L; Brooks PC
Cancer Res; 2007 May; 67(9):4353-63. PubMed ID: 17483349
[TBL] [Abstract][Full Text] [Related]
9. Interplay of mevalonate and Hippo pathways regulates RHAMM transcription via YAP to modulate breast cancer cell motility.
Wang Z; Wu Y; Wang H; Zhang Y; Mei L; Fang X; Zhang X; Zhang F; Chen H; Liu Y; Jiang Y; Sun S; Zheng Y; Li N; Huang L
Proc Natl Acad Sci U S A; 2014 Jan; 111(1):E89-98. PubMed ID: 24367099
[TBL] [Abstract][Full Text] [Related]
10. Increased shedding of HU177 correlates with worse prognosis in primary melanoma.
Hamilton HK; Rose AE; Christos PJ; Shapiro RL; Berman RS; Mazumdar M; Ma MW; Krich D; Liebes L; Brooks PC; Osman I
J Transl Med; 2010 Feb; 8():19. PubMed ID: 20178639
[TBL] [Abstract][Full Text] [Related]
11. Palmitic acid dysregulates the Hippo-YAP pathway and inhibits angiogenesis by inducing mitochondrial damage and activating the cytosolic DNA sensor cGAS-STING-IRF3 signaling mechanism.
Yuan L; Mao Y; Luo W; Wu W; Xu H; Wang XL; Shen YH
J Biol Chem; 2017 Sep; 292(36):15002-15015. PubMed ID: 28698384
[TBL] [Abstract][Full Text] [Related]
12. Targeting the cyclin-dependent kinase 5 in metastatic melanoma.
Sharma S; Zhang T; Michowski W; Rebecca VW; Xiao M; Ferretti R; Suski JM; Bronson RT; Paulo JA; Frederick D; Fassl A; Boland GM; Geng Y; Lees JA; Medema RH; Herlyn M; Gygi SP; Sicinski P
Proc Natl Acad Sci U S A; 2020 Apr; 117(14):8001-8012. PubMed ID: 32193336
[TBL] [Abstract][Full Text] [Related]
13. SRC tyrosine kinase activates the YAP/TAZ axis and thereby drives tumor growth and metastasis.
Lamar JM; Xiao Y; Norton E; Jiang ZG; Gerhard GM; Kooner S; Warren JSA; Hynes RO
J Biol Chem; 2019 Feb; 294(7):2302-2317. PubMed ID: 30559289
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of experimental metastasis by targeting the HUIV26 cryptic epitope in collagen.
Roth JM; Caunt M; Cretu A; Akalu A; Policarpio D; Li X; Gagne P; Formenti S; Brooks PC
Am J Pathol; 2006 May; 168(5):1576-86. PubMed ID: 16651624
[TBL] [Abstract][Full Text] [Related]
15. The Hippo pathway target, YAP, promotes metastasis through its TEAD-interaction domain.
Lamar JM; Stern P; Liu H; Schindler JW; Jiang ZG; Hynes RO
Proc Natl Acad Sci U S A; 2012 Sep; 109(37):E2441-50. PubMed ID: 22891335
[TBL] [Abstract][Full Text] [Related]
16. Calmodulin activates the Hippo signaling pathway by promoting LATS1 kinase-mediated inhibitory phosphorylation of the transcriptional coactivator YAP.
Thines L; Gorisse L; Li Z; Sayedyahossein S; Sacks DB
J Biol Chem; 2022 May; 298(5):101839. PubMed ID: 35307353
[TBL] [Abstract][Full Text] [Related]
17. The Hippo pathway oncoprotein YAP promotes melanoma cell invasion and spontaneous metastasis.
Zhang X; Yang L; Szeto P; Abali GK; Zhang Y; Kulkarni A; Amarasinghe K; Li J; Vergara IA; Molania R; Papenfuss AT; McLean C; Shackleton M; Harvey KF
Oncogene; 2020 Jul; 39(30):5267-5281. PubMed ID: 32561850
[TBL] [Abstract][Full Text] [Related]
18. Cryptic collagen elements as signaling hubs in the regulation of tumor growth and metastasis.
Han X; Caron JM; Brooks PC
J Cell Physiol; 2020 Dec; 235(12):9005-9020. PubMed ID: 32400053
[TBL] [Abstract][Full Text] [Related]
19. Pro-invasive activity of the Hippo pathway effectors YAP and TAZ in cutaneous melanoma.
Nallet-Staub F; Marsaud V; Li L; Gilbert C; Dodier S; Bataille V; Sudol M; Herlyn M; Mauviel A
J Invest Dermatol; 2014 Jan; 134(1):123-132. PubMed ID: 23897276
[TBL] [Abstract][Full Text] [Related]
20. Thromboxane A2 Activates YAP/TAZ Protein to Induce Vascular Smooth Muscle Cell Proliferation and Migration.
Feng X; Liu P; Zhou X; Li MT; Li FL; Wang Z; Meng Z; Sun YP; Yu Y; Xiong Y; Yuan HX; Guan KL
J Biol Chem; 2016 Sep; 291(36):18947-58. PubMed ID: 27382053
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
